Dichotomous Nitric Oxide–Dependent Post-Translational Modifications of STAT1 Are Associated with Ipilimumab Benefits in Melanoma

SIMPLE SUMMARY: Nitric oxide is typically thought of as an inhibitory molecule in cancer. In our previous studies, nitric oxide (NO) increased in the immune effector cells among patients with longer RFS after adjuvant ipilimumab, whereas NO increased in the immune suppressor cells among patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Garg, Saurabh K., Sun, James, Kim, Youngchul, Whiting, Junmin, Sarnaik, Amod, Conejo-Garcia, José R., Phelps, Mitch, Weber, Jeffrey S., Mulé, James J., Markowitz, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046641/
https://www.ncbi.nlm.nih.gov/pubmed/36980641
http://dx.doi.org/10.3390/cancers15061755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046641/
https://www.ncbi.nlm.nih.gov/pubmed/36980641
http://dx.doi.org/10.3390/cancers15061755

Ejemplares similares